A. Nakamura et al., beta(2)-Adrenoceptor agonist suppresses tumour necrosis factor production in rat mesangial cells, CYTOKINE, 12(5), 2000, pp. 491-494
This study aimed to investigate the time-course of the effect of beta(2)-ad
renoceptor stimulation with terbutaline on lipopolysaccharide (LPS)-induced
tumour necrosis factor(TNF)-alpha production in rat mesangial cells. Cells
were cultured from 0-24 h in the presence of LPS (1 mu g/ml) and/or terbut
aline (10(-7)-10(-8) mol/l). After 1 h of incubation, terbutaline inhibited
TNF-alpha protein release as well as transcription and translation of TNF-
alpha and mitogen activated protein kinase (MAPK, p42/p44) activity. At 3h,
terbutaline enhanced intracellular cAMP but suppressed TNF-alpha release a
nd transcription. By 24 h, whereas terbutaline was no longer influencing tr
anscription or translation, TNF-alpha release remained depressed which corr
elated with an increase in supernatant interleukin (IL)-6, Terbutaline did
not affect the LPS-induced IL-10 produced in the cell. These findings indic
ate that beta(2)-adrenoceptor stimulation during an LPS challenge prevented
TNF-alpha production as consequence of MAPK inhibition and enhanced cAMP g
eneration, which at a later stage was associated with an anti-inflammatory
effect of IL-6. (C) 2000 Academic Press.